Lithium succinate
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| PubChem CID | |
| ECHA InfoCard | 100.163.153 |
| Chemical and physical data | |
| Formula | C4H6LiO4+ |
| Molar mass | 125.029 g/mol |
Lithium succinate is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]
References
- ^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel). 187 (2): 149–50. PMID 8358107.
- ^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS. 8 (8): 515–7. PMID 9259500.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |